On December 21, 2023 Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, reported that the company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 (Press release, Carisma Therapeutics, DEC 21, 2023, View Source [SID1234638760]). Steven Kelly, President and Chief Executive Officer, will make a formal presentation and answer questions about the company at 11:15 a.m. PST.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Live webcasts will be available on the Company’s Investor Events webpage. A replay of the webcasts will be archived at the Company’s past events section of the Investor Relations webpage for a limited time following the event.